637-10034-20807
3 vaccinations
8 coded responses
34 check-ins
8 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 751 / TX
- Registered
- 2021-01-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Registered dependents
2QW-16430-90616
Child or adolescent in my care · Female · 2021-11-19
Timeline
-
2021-01-27
Registered in v-safe
-
2021-01-27
Dose 1 — Pfizer-BioNTech
- 2021-01-27
-
2021-01-28
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-29
Survey response — days 1–6 daily, dose 1MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Swollen and painful lymph nodes on side on injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Fair · Muscle or body aches, Fatigue or tirednessFree text: Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Good · Muscle or body aches · Be unable to do your normal daily activitiesFree text: Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Good · Muscle or body achesFree text: Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-03
- 2021-02-17
-
2021-02-23
Dose 2 — Pfizer-BioNTech
- 2021-02-23
-
2021-02-24
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Extreme dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-02-28
-
2021-03-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-02
Health check-in — day 7, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-09
- 2021-03-16
- 2021-03-23
- 2021-04-01
- 2021-04-06
- 2021-05-25
- 2021-08-26
-
2021-11-18
Dose 3 — Pfizer-BioNTech
-
2021-11-19
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-22
- 2021-11-24
- 2021-11-27
-
2021-12-02
Survey response — day 14, dose 3MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: FatigueMedDRA releases: 2024-11 · check-in free text available
- 2021-12-09
- 2021-12-16
-
2021-12-23
Survey response — day 35, dose 3MedDRA: Fatigue, Headache, Oropharyngeal pain, Pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Runny nose Congestion Headache Body aches Fatigue Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-02-20
Survey response — 3 months, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
- 2022-05-21
- 2022-11-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Pfizer-BioNTech | |
| 2 | 2021-02-23 | Pfizer-BioNTech | |
| 3 | 2021-11-18 | Pfizer-BioNTech | No |
Free text
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): Swollen and painful lymph nodes on side on injection
Systemic reaction (other): Swollen lymph nodes
Systemic reaction (other): Swollen lymph nodes
Systemic reaction (other): Swollen lymph nodes
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Extreme dizziness
Release 10 — day 14, dose 3
Symptoms: Fatigue
Release 10 — day 35, dose 3
Symptoms: Runny nose Congestion Headache Body aches Fatigue Sore throat
Release 11 — 3 months, dose 3
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release